CYCN
Cyclerion Therapeutics, Inc.
$3.25
+1.25%
$14.1M
No data for this timeframe.
Vol
Market Cap$14.1M
Cap SizeNano Cap
Inst. Holders8 funds
Inst. Value$97.8K
Inst. Activity2 buys / 1 sells
Reddit Sentiment70° Bullish
SEC Reports3
Recent Activity
Jun 9, 2026
SEC
Cyclerion Therapeutics files S-4/A for reverse merger with Korsana Biosciences. Current CYCN shareholders will own ~1.5%
S-4/A — Impact 7/10
May 14, 2026
earnings_calendar
CYCN Q1 2026 Earnings Scheduled — 2026-05-14
Apr 30, 2026
SEC
This is a routine 10-K/A amendment filed solely to include Part III items (director/officer info, executive compensation
10-K/A — Impact 3/10
Apr 1, 2026
SEC
Cyclerion Therapeutics (CYCN) is being acquired by Korsana Biosciences in a reverse merger where Korsana becomes the sur
425 — Impact 7/10
Inst.
TWO SIGMA INVESTMENTS, LP — DOUBLED
41,555 shares ($52.8K)
Inst.
BANK OF AMERICA CORP — DOUBLED
107 shares ($136.00)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$8.00
Current $3.25
Low $8.00
Median $8.00
High $8.00
1 analysts
$8.00
$8.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-1.20 | $-1.20 — $-1.20 | -8% YoY | 1 |
| Next FY | $-0.99 | $-0.99 — $-0.99 | 18% YoY | 1 |
Latest Reports
BEARISH
S-4/A
7/10
Cyclerion Therapeutics files S-4/A for reverse merger with Korsana Biosciences. Current CYCN shareholders will own ~1.5%
Jun 9, 2026
NEUTRAL
10-K/A
3/10
This is a routine 10-K/A amendment filed solely to include Part III items (director/officer info, executive compensation
Apr 30, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $28.0K | — |
| BlackRock, Inc. | $26.0K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.8K | — |
| VANGUARD FIDUCIARY TRUST CO | $11.3K | — |
| FMR LLC | $7.3K | NEAR_EXIT |
Reddit Sentiment
70°▼
Bullish
Bearish
Neutral
Bullish
8 institutional holders with $97.8K total value (63,570 shares) as of 2026-Q1. Top holders: CITADEL, BlackRock,, VANGUARD.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 18,261 | $28.0K | 28.7% | — |
| 2 | BlackRock, Inc. | 16,797 | $26.0K | 26.6% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 16,137 | $24.8K | 25.3% | — |
| 4 | VANGUARD FIDUCIARY TRUST CO | 7,353 | $11.3K | 11.5% | — |
| 5 | FMR LLC | 4,740 | $7.3K | 7.4% | NEAR_EXIT -97.0% |
| 6 | GROUP ONE TRADING LLC | 192 | $295.00 | 0.3% | — |
| 7 | CITIGROUP INC | 89 | $137.00 | 0.1% | — |
| 8 | MORGAN STANLEY | 1 | $2.00 | 0.0% | NEAR_EXIT -99.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 13,293 | 41,555 | +212.6% | $52.8K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 22 | 107 | +386.4% | $136.00 | 2025-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 649 | 1 | -99.8% | $2.00 | 2025-Q4 |
| UBS Group AG | NEAR_EXIT | 9,727 | 49 | -99.5% | $113.00 | 2025-Q3 |
| UBS Group AG | TRIM | 13,001 | 9,727 | -25.2% | $28.3K | 2025-Q2 |
| UBS Group AG | ADD | 9,667 | 13,001 | +34.5% | $32.5K | 2025-Q1 |
| UBS Group AG | DOUBLED | 145 | 9,667 | +6566.9% | $31.1K | 2024-Q4 |
| FMR LLC | NEAR_EXIT | 157,636 | 4,740 | -97.0% | $15.3K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 16 | 23 | +43.8% | $59.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 1 neutral. Avg impact: 5.7/10.
BEARISH
S-4/A
7/10
Cyclerion Therapeutics files S-4/A for reverse merger with Korsana Biosciences. Current CYCN shareho
Jun 9, 2026
NEUTRAL
10-K/A
3/10
This is a routine 10-K/A amendment filed solely to include Part III items (director/officer info, ex
Apr 30, 2026
MIXED
425
7/10
Cyclerion Therapeutics (CYCN) is being acquired by Korsana Biosciences in a reverse merger where Kor
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$8.00 mean target
$8.00 Low
$8.00 High
| Metric | Value |
|---|---|
| Current Price | $3.25 |
| Target Low | $8.00 |
| Target Mean | $8.00 |
| Target Median | $8.00 |
| Target High | $8.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$-1.20 | $-1.20 | $-1.20 | -8.1% | — | — | $0.0B | -100.0% | 1 |
| Next FY 2027-12-31 |
$-0.99 | $-0.99 | $-0.99 | 17.5% | — | — | $0.0B | 0.0% | 1 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
70°
Bullish
Bearish
Neutral
Bullish
6 mentions
4 bullish
0 bearish
6 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 5, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Apr 5, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Apr 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 1, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 1, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Stock Pulse Weekly Recap — Mar 31 – Apr 4, 2026
▲ 1
💬 1
⚡ 0.5
$CYCN +183% — Korsana merger and $380M financing
▲ 1
💬 1
⚡ 0.5
May 14, 2026
earnings_calendar
CYCN Q1 2026 Earnings Scheduled — 2026-05-14
May 4, 2026
earnings_calendar
CYCN Q1 2026 Earnings Scheduled — 2026-05-04
Apr 9, 2026
short_volume
Short Volume: CYCN — 56.1% short (0.7M / 1.2M)
Short: 671,926 | Exempt: 124,320 | TRF Vol: 1,198,415 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_interest
FTD: CYCN — 287,350 shares ($1.8M) failed to deliver
Settlement: 20260406, Price: $6.15, FTD Value: $1,767,202.5, CYCLERION THERAPEUTICS INC COM
Apr 2, 2026
short_volume
Short Volume: CYCN — 57.7% short (2.8M / 4.8M)
Short: 2,756,860 | Exempt: 383,395 | TRF Vol: 4,774,918 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_interest
FTD: CYCN — 258,518 shares ($1.6M) failed to deliver
Settlement: 20260402, Price: $6.38, FTD Value: $1,649,344.84, CYCLERION THERAPEUTICS INC COM
Apr 1, 2026
short_volume
Short Volume: CYCN — 58.3% short (48.3M / 82.8M)
Short: 48,299,771 | Exempt: 565,209 | TRF Vol: 82,849,006 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
Mar 2, 2026
earnings_calendar
CYCN Q4 2025 Earnings Scheduled — 2026-03-02